Kelsey Financial’s Amgen AMGN Stock Holding History

Kelsey Financial’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.89M	Sell	21,792 -6	-0%	-$2.05K	5.99%	6
2026 Q1	$7.67M	Buy	21,798 +2	+0%	+$713	6.71%	5
2025 Q4	$7.13M	Buy	+21,796	New	+$6.91M	6.13%	6

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Kelsey Financial's AMGN Position: Q2 2026 in Review

Kelsey Financial reduced its Amgen (AMGN) stake by 0.03% in Q2 2026, selling an estimated $2.05K and leaving 21,792 shares worth $7.89M. The position accounts for 5.99% of the portfolio, ranked #6.

Kelsey Financial first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Kelsey Financial held 21,792 shares of Amgen worth $7.89M as of Q2 2026.
Kelsey Financial sold 6 Amgen shares in Q2 2026, an estimated $2.05K.
Amgen made up 5.99% of Kelsey Financial's portfolio in Q2 2026, its #6 holding.
Kelsey Financial first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kelsey Financial's 13F filing for Q2 2026, filed 10 Aug 2026.